Applied DNA Sciences Inc（APDN）资讯与事件APDNApplied DNA Sciences Inc

Applied DNA reveals private placement plan to raise up to $58M for BNB treasury initiation.

Applied DNA Sciences announced up to $58M in commitments for a private investment in public equity, or "PIPE," offering led by institutional investors to initiate a digital asset treasury strategy based on BNB, the native cryptocurrency of the Binance blockchain ecosystem. Following the closing, the company intends to begin deploying funds to acquire BNB, creating a gateway for institutional and retail investors to participate in the BNB blockchain and Binance ecosystem. The company intends to change its ticker symbol to "BNBX" to reflect its strategic focus on its BNB treasury strategy. The company has secured total commitments of $27M, comprised of cash, stablecoin and units of the OBNB Trust in the PIPE with the potential for up to an additional $31M in gross proceeds in future investment from warrant exercises, for total gross proceeds of up to $58M. The closing of the PIPE is expected to occur on or about October 1, subject to the satisfaction of customary closing conditions. To support its BNB treasury strategy the company entered into a five-year Strategic Digital Assets Services Agreement with Cypress to provide discretionary asset management services. In addition, the company entered into a five-year Strategic Advisor Agreement with Cypress Management, an affiliate of Cypress LLC, to provide strategic and technical guidance on business operations relating to its BNB treasury strategy. "The company plans to implement a differentiated digital asset treasury strategy designed to generate additional yield and accumulation of BNB tokens through the integration of actively managed decentralized finance protocols and Binance ecosystem specific strategies. Unlike passive staking or even traditional validator operating strategies, we believe this more active approach is structured to deliver yields materially in excess of other conventional methods, while maintaining a disciplined focus on risk management. The strategy is further strengthened by active engagement within the BNB and Binance ecosystem, employing a sophisticated yield framework that prioritizes stability, scalability, and transparency. By combining robust oversight with innovative on-chain opportunities, the company believes it is positioning its treasury as a driver of sustainable growth and long-term value creation," it stated.

Applied DNA Sciences announces new follow-on LineaDNA order

Applied DNA Sciences received a seventh follow-on order valued at more than $600,000 for a multi-gram quantity of LineaDNA. The follow-on order was placed by a global manufacturer of in vitro diagnostics under a long-standing supply agreement for the bulk manufacture of LineaDNA used as a functional component of a cancer diagnostic test. Deliveries are scheduled across four quarterly shipments beginning in the second quarter of fiscal 2026.

Applied DNA regains compliance with Nasdaq continued listing requirements

Applied DNA Sciences received written notice from The Nasdaq Stock Market informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share, and that the Company is therefore in compliance with the Nasdaq Capital Market's listing requirements. Nasdaq also notified the Company in the Compliance Notice that the hearing before the Nasdaq Hearings Panel previously scheduled to take place on July 15, 2025, has been cancelled, and the Company's securities will continue to be listed and traded on The Nasdaq Capital Market.